HTFL

SEC source: 0001464521-26-000154 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 283,014

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

F2 · price: This transaction was executed in multiple trades at price ranging from $49.52 to $50.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001464521-26-000152 · form4.xml · derivative · entry 9

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,783

Underlying: Common Stock · 850 shares

Expires 2033-07-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.

F4 · derivative.exercise_date: The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.

SEC source: 0001464521-26-000152 · form4.xml · derivative · entry 8

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,456

Underlying: Common Stock · 12,329 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.

F3 · derivative.exercise_date: These stock options are fully exercisable.

SEC source: 0001464521-26-000152 · form4.xml · nonDerivative · entry 3

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,956

F2 · kind: Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 13,179 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.

SEC source: 0001464521-26-000152 · form4.xml · nonDerivative · entry 2

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 99,638

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.

SEC source: 0001464521-26-000152 · form4.xml · nonDerivative · entry 1

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,788

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.

SEC source: 0001464521-26-000147 · form4.xml · nonDerivative · entry 3

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 179,528

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.

F4 · price: This transaction was executed in multiple trades at price ranging from $50.00 to $50.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001464521-26-000147 · form4.xml · nonDerivative · entry 2

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,196

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.

F3 · price: This transaction was executed in multiple trades at price ranging from $50.00 to $50.62. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001464521-26-000147 · form4.xml · nonDerivative · entry 1

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,789

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.

F2 · price: This transaction was executed in multiple trades at price ranging from $50.06 to $50.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001464521-26-000145 · form4.xml · nonDerivative · entry 2

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 321,914

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

SEC source: 0001464521-26-000145 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 325,804

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

F2 · price: This transaction was executed in multiple trades at price ranging from $45.43 to $47.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001464521-26-000143 · form4.xml · nonDerivative · entry 1

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 214,503

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.

F2 · price: This transaction was executed in multiple trades at price ranging from $50.00 to $50.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001464521-26-000141 · form4.xml · nonDerivative · entry 2

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 221,143

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.

F2 · price: This transaction was executed in multiple trades at price ranging from $48.22 to $50.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001464521-26-000141 · form4.xml · nonDerivative · entry 1

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 248,683

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.

SEC source: 0001464521-26-000139 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 360,814

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

SEC source: 0001464521-26-000137 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 388,044

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

SEC source: 0001464521-26-000135 · form4.xml · derivative · entry 7

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,972

Underlying: Common Stock · 9,219 shares

Expires 2035-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.

F2 · derivative.exercise_date: The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.

SEC source: 0001464521-26-000135 · form4.xml · nonDerivative · entry 2

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,459

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.

SEC source: 0001464521-26-000135 · form4.xml · nonDerivative · entry 1

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,678

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.

SEC source: 0001464521-26-000133 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 420,720

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

SEC source: 0001464521-26-000127 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 436,280

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

SEC source: 0001464521-26-000121 · form4.xml · nonDerivative · entry 3

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,559

F2 · shares: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

SEC source: 0001464521-26-000119 · form4.xml · nonDerivative · entry 2

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,459

F1 · shares: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

SEC source: 0001464521-26-000123 · form4.xml · nonDerivative · entry 3

Jones Marie L. · CIK 0001968991 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,176

F2 · shares: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

SEC source: 0001464521-26-000117 · form4.xml · nonDerivative · entry 2

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 458,842

F1 · shares: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

SEC source: 0001464521-26-000121 · form4.xml · nonDerivative · entry 2

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,032

F2 · shares: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

SEC source: 0001464521-26-000119 · form4.xml · nonDerivative · entry 1

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,096

F1 · shares: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

SEC source: 0001464521-26-000123 · form4.xml · nonDerivative · entry 2

Jones Marie L. · CIK 0001968991 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,258

F2 · shares: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

SEC source: 0001464521-26-000117 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 460,746

F1 · shares: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

SEC source: 0001464521-26-000115 · form4.xml · derivative · entry 6

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,043

Underlying: Common Stock · 9,737 shares

Expires 2034-12-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests and becomes exercisable in monthly installments until November 12, 2028, subject to continued service through the applicable vesting date.

SEC source: 0001464521-26-000115 · form4.xml · derivative · entry 5

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,703

Underlying: Common Stock · 2,789 shares

Expires 2031-08-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options are fully exercisable.

SEC source: 0001464521-26-000115 · form4.xml · derivative · entry 4

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,984,637

Underlying: Common Stock · 18,694 shares

Expires 2033-07-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.

SEC source: 0001464521-26-000115 · form4.xml · nonDerivative · entry 3

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 466,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001464521-26-000115 · form4.xml · nonDerivative · entry 2

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 456,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001464521-26-000115 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,162

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001464521-26-000113 · form4.xml · derivative · entry 2

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,588

Underlying: Common Stock · 22,522 shares

Expires 2033-12-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vests and becomes exercisable in monthly installments until October 30, 2027, subject to continued service through the applicable vesting date.

SEC source: 0001464521-26-000113 · form4.xml · nonDerivative · entry 1

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001464521-26-000111 · form4.xml · derivative · entry 5

Lightcap Jeffrey C · CIK 0001519465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 47,420 shares

Expires 2035-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options are fully exercisable.

SEC source: 0001464521-26-000111 · form4.xml · nonDerivative · entry 1

Lightcap Jeffrey C · CIK 0001519465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001464521-26-000109 · form4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 3,710 shares

Expires 2035-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These stock options are fully exercisable.

SEC source: 0001464521-26-000109 · form4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001464521-26-000107 · form4.xml · derivative · entry 2

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,110

Underlying: Common Stock · 22,522 shares

Expires 2033-12-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vests and becomes exercisable in monthly installments until October 30, 2027, subject to continued service through the applicable vesting date.

SEC source: 0001464521-26-000107 · form4.xml · nonDerivative · entry 1

Verghese Vikram · CIK 0002079946 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001464521-26-000105 · form4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,710

Underlying: Common Stock · 5,000 shares

Expires 2035-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These stock options are fully exercisable.

SEC source: 0001464521-26-000105 · form4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001464521-26-000103 · form4.xml · derivative · entry 7

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,191

Underlying: Common Stock · 9,219 shares

Expires 2035-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.

F2 · derivative.exercise_date: The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.

SEC source: 0001464521-26-000103 · form4.xml · nonDerivative · entry 2

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,731

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.

SEC source: 0001464521-26-000103 · form4.xml · nonDerivative · entry 1

Rogers Campbell · CIK 0001585724 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.

SEC source: 0001464521-26-000101 · form4.xml · nonDerivative · entry 1

Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 435,373

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

SEC source: 0001464521-26-000099 · form4.xml · derivative · entry 6

WELDON WILLIAM C · CIK 0001189019 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,123 shares

Expires 2027-09-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These stock options are fully exercisable.